On the 25th anniversary of 9/11, TBE reached out to the community for personal remembrances of that tragic day. Here is one ...

Long-term humoral immunity relies on long-lived plasma cells in the bone marrow (BM). However, the processes governing plasma ...

The tragedy of Sept. 11, 2001 is still felt in our nation today as we come to the 25th anniversary of one of our nation's ...

Rose covers disability and mental health, and she helps write STAT’s daily Morning Rounds newsletter. Confidential tips can be sent to Rose on Signal at rosebroderick.11. Two years ago, scientists ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Germany's Merck KGaA pledged Thursday to buy Bio-Techne (TECH) for $11.3 billion. The deal expands its portfolio of reagents, life sciences tools and diagnostic products. Bio-Techne stock rocketed ...

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the Minneapolis-based group Bio-Techne, according to a news release posted ...

Germany’s Merck MRK0.11%increase; up pointing triangle KGaA said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne TECH-0.17%decrease; down pointing triangle for $11.3 billion, in ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the German pharma and technology group’s biggest acquisition in more than a decade ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal represents a 36% ...

Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota history. The sale follows investor pressure on Minneapolis-based Bio-Techne, ...